Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination

BACKGROUND: Sunitinib is a standard treatment for metastatic renal cell carcinoma. Angiotensin system inhibitors, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, are widely used in hypertension, kidney disease, and heart failure. Data suggests that they may i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Keizman, Daniel, Huang, Peng, Eisenberger, Mario A., Pili, Roberto, Kim, Jenny J., Antonarakis, Emmanuel S., Hammers, Hans, Carducci, Michael A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3175366/
https://ncbi.nlm.nih.gov/pubmed/21600760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2011.04.019
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller